ENZYMATIC SUBCISION AND REMODELING (ESR)
Dead / Abandoned — Abandoned — failure to respond (as of 01 Dec 2022)
What this means for you
This application is over — abandoned 21 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90902951
- Mark type
- Stylized text
- Filed
- 25 Aug 2021
- Abandoned
- 21 Nov 2022
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; pharmaceutical skin lotions; medicated gels and creams for dermatological use
- Class 042 — Scientific and technological services: Medical research in the fields of chemicals and pharmaceuticals; Scientific research in the field of therapeutic aesthetic solutions; scientific research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; development of pharmaceutical products to specifications of others; providing medical research information, namely, case studies in the field of therapeutic aesthetic solutions; development of medical solutions and processes to release the cellulite dimple
Owner
- Endo Pharmaceuticals Inc., Malvern, PA, US
Prosecution history
- 01 Dec 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Dec 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 01 Dec 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 18 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2022 — NON-FINAL ACTION E-MAILED
- 18 May 2022 — NON-FINAL ACTION WRITTEN
- 10 May 2022 — ASSIGNED TO EXAMINER
- 11 Jan 2022 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 10 Jan 2022 — ASSIGNED TO LIE
- 06 Jan 2022 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 12 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Aug 2021 — NEW APPLICATION ENTERED